A Demand Notice paper publication has been issued to the Company by Hinduja Leyland Finance Limited for the default in outstanding term loan provided by them
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Indrayani Biotech has disclosed that Hinduja Leyland Finance Limited, an NBFC, published a SARFAESI Demand Notice in The New Indian Express on 30 January 2026 after classifying the company's term loans as a Non-Performing Asset. The default date is 26 December 2025, with current overdue amounts of Rs. 47.56 lakh as a direct borrower and Rs. 1.41 crore as a co-borrower alongside seven other co-borrowers. The total outstanding under these facilities is Rs. 6.46 crore (as borrower) and Rs. 19.12 crore (as co-borrower), secured at 13% interest with a 120-month tenure. The company's total financial indebtedness stands at around Rs. 54.48 crore, of which about Rs. 41 crore is owed to banks and financial institutions. The company says it is evaluating the notice and will take steps to regularize its accounts.
This is a negative signal for shareholders — it points to serious liquidity stress and the risk of secured asset seizure under the SARFAESI Act if the default is not resolved. Watch for further updates on repayment or restructuring, as this could weigh on the stock and raise concerns about the company's overall debt health.